
Episode 774: China’s anti-obesity drug efforts vs the “gym office” trend
Commercial Awareness with Watson’s Daily business and financial news
00:00
Introduction
Chinese drug makers are developing weight loss drugs to tackle China's high rates of obesity and diabetes, with around 89 million people living with diabetes. The chapter examines the potential impact of cheaper Chinese drugs on the market and factors that could influence consumer choices.
Transcript
Play full episode